Postnatal & Postpartum Recovery

Postnatal & Postpartum Recovery: A Nutrition and Natural-Health Reference

1. Definition and Scope

The postpartum period is the period after delivery of the conceptus when maternal physiological and anatomical changes return to the nonpregnant state. Also known as the puerperium, it starts following the expulsion of the placenta and continues until the complete physiological recovery of various organ systems.

The postpartum period is divided into three arbitrary phases: the acute phase — the first 24 hours after delivery of the placenta; the early phase — up to 7 days; and the late phase — up to 6 weeks to 6 months. Each phase has its unique clinical considerations and challenges. In a broader nutritional and natural-health context, full recovery — including replenishment of depleted micronutrient stores, hormonal re-equilibration, and restoration of musculoskeletal integrity — may extend considerably beyond the traditional six-week mark, particularly in women who breastfeed.

2. Body Systems Involved

2.1 Cardiovascular and Haematological Systems

A few recent studies report an increase in right ventricular volume and mass by 40% during pregnancy; the physiological hypertrophy of the ventricular system reverts to the pre-pregnant state in approximately 4 weeks postpartum. There is generalized physical fatigue immediately after delivery. The pulse rate may be elevated a few hours after childbirth due to excitement or pain, and usually normalises on the second day.

Blood volume contraction following delivery drives significant haematological shifts. Dietary iron requirements during the postpartum period decrease to nonpregnant levels unless blood loss exceeded the usual amount lost during a vaginal delivery (approximately 500 ml). Haemoglobin and haematocrit values ordinarily rise post partum with the contraction of blood volume to nonpregnant levels; in addition, the gradual disintegration of excess red blood cells releases iron that can be used for the synthesis of new haemoglobin.

Despite this physiological recycling, postpartum anaemia remains a major global health concern. Although maternal iron stores are expected to replenish after delivery, the prevalence of anaemia in women after childbirth remains high, in both developed (22–50%) and developing (50–80%) countries. Iron deficiency is the main cause and constitutes a potentially preventable condition with great impact on the mother's physical and mental condition after delivery. In most cases, postpartum anaemia is associated with antenatal iron deficiency and peripartum blood losses.

2.2 Reproductive and Endocrine Systems

The postpartum period involves complex physiological changes, notably in hormone levels, that significantly influence immune system function. Hormonal regulation during pregnancy prevents maternal immune rejection of the fetus, but following childbirth, these hormone levels drop rapidly, leading to immune reconstitution.

Postpartum immune reactivation, triggered by hormonal shifts, can lead to a resurgence of inflammatory reactions. This process, characterised by increased cortisol and prolactin levels and a rapid decline in estrogen and progesterone, could exacerbate dormant autoimmune conditions or trigger latent infections, making this period especially vulnerable to immune-related complications. Hormonal and immune responses are closely interdependent in the postpartum period, leading to heightened susceptibility to infections, autoimmune flare-ups, and other immune-related disorders.

2.3 Gastrointestinal System

The mother may develop flatulence or constipation due to intestinal ileus (induced by pain or the presence of placental hormone relaxin in the circulation), loss of body fluids, laxity of the abdominal wall, and haemorrhoids. Postpartum constipation is attributable to the progesterone-induced decrease in gastrointestinal transit time.

2.4 Musculoskeletal System and Bone Metabolism

Lactation exerts a distinct and significant effect on maternal bone. Serial bone density measurements obtained during lactation show a fall of 3–10% in trabecular bone (spine, hip, femur) with a smaller 1–2% loss at cortical bone. Both losses are far greater than that seen in early postmenopausal women, or in women receiving GnRH agonist therapy, implying that it is not only the fall in oestrogen that mediates bone loss during lactation. The bone loss during lactation seems to be transient, as there is rapid recovery of bone density in postpartum women with weaning and the resumption of menses.

Although bone loss occurs throughout pregnancy and persists into lactation irrespective of calcium intake, observational studies have demonstrated a complete recovery of bone mass in the majority of women within the first 1–2 years postpartum.

2.5 Body Composition

Body composition measurements at 2 days, 2 weeks, and 6 weeks postpartum have shown that weight decreases during this postpartum period; the postpartum weight retention from prepregnancy to 6 weeks postpartum was approximately 4.43 kg. Among various body composition components, extracellular water, intracellular water, total body water, and fat-free mass decreased postpartum. However, fat mass and visceral fat area — the components that experienced the greatest changes — increased postpartum. The postpartum period is therefore associated with a preferential accumulation of adipose tissue in the visceral compartment, even though overall body weight is decreased.

2.6 Neurological and Mental Health

Postpartum depression (PPD) is prevalent globally and is a significant public health concern. Epidemiological studies indicate that 10–20% of women worldwide experience PPD. PPD is a challenging psychological disorder faced by 10–30% of mothers across the globe; in India, it occurs among approximately 22% of mothers. Its aetiology and pathophysiology are not fully understood, but multiple theories on the interplay of hormones, neurotransmitters, genetics, epigenetics, nutrients, and socio-environmental factors exist.

3. Contributing and Associated Factors

3.1 Nutritional Depletion

Milk quantity and quality are maintained reasonably well within a wide range of maternal diets, presumably reflecting subsidy of lactation by maternal stores. The Recommended Dietary Allowances (RDAs) for most nutrients are increased during lactation — in some cases by more than 50%. The extra nutrient intake needed to cover exclusive breastfeeding for 4 to 6 months is substantially greater than that needed to cover the entire pregnancy.

Depression is a significant complication of the peripartum period. Micronutrient imbalances could contribute to the development of perinatal depression through their roles in neurotransmitter synthesis and neuroendocrine and neuroimmune pathways. Micronutrient imbalances are more likely during the perinatal period due to the additional physiological demands on the body at this time.

3.2 Blood Loss and Anaemia

Women who have previously been pregnant sustain between 500 mg and 600 mg of iron loss per pregnancy, which includes addition to daily iron loss during that part of gestation. Iron requirement directed towards the fetus and the placenta amounts to 300–350 mg, and puerperal blood loss accounts for a further 200–250 mg. Insufficient iron intake, gestational anaemia or iron deficiency, and postpartum haemorrhage are associated with lower postpartum haemoglobin concentration and poorer iron status.

3.3 Hormonal and Immunological Shifts

Hormonal influences — particularly of cortisol, prolactin, estrogen, and progesterone — are central to immune reconstitution with associated inflammatory responses in the postpartum period. The rapid post-delivery decline in estrogen and progesterone, combined with surging prolactin (to support lactation), creates a state of hormonal flux that affects neurotransmitter balance, bone metabolism, thyroid function, and mood regulation.

3.4 Sociodemographic and Dietary Behaviour Factors

Changes in energy intake vary considerably between studies; however, there is a general trend toward a significant increase in energy intake in lactating women 3–4 months postpartum compared with the third trimester, because lactation is the period when the mother has increased nutritional requirements to produce milk and to compensate for the demands of breastfeeding. Women with lower education level, lower income, and/or who work full-time tend to have poorer dietary behaviours post-pregnancy.

3.5 Sleep Disruption

Fatigue from poor sleep hinders postpartum exercise, yet exercise improves both mood and sleep quality. While wanting to maintain a healthy diet, fatigue from inadequate sleep also influences food choices. Poor sleep exacerbates cravings for high-energy, processed foods; interventions that include examples of nutrient-dense and quick-to-prepare meal options may promote both energy stability and sleep quality.

3.6 Body Mass Index and Fatigue

At six months postpartum, PPD was positively correlated to BMI and fatigue, and negatively correlated to household income. Mothers who were breastfeeding had lower PPD scores compared to those who were not breastfeeding.

4. Key Nutrients in Postpartum Recovery

4.1 Iron

Iron deficiency is the main cause of postpartum anaemia and constitutes a potentially preventable condition with great impact on the mother's physical and mental condition after delivery. In most cases, postpartum anaemia is associated with antenatal iron deficiency and peripartum blood losses.

Scientific Evidence: In a population-based cohort study of 573 women, the prevalence of postpartum anaemia (Hb <12.0 g/dl) was 25% at 14 weeks postpartum. Iron deficiency prevalence varied from 39% by serum ferritin to 19% by soluble transferrin receptor. In terms of mental health outcomes, a review of studies revealed that in 4 out of 5 clinical trials, iron supplementation during the postpartum period was associated with lower risk of depression. The evidence base supports iron supplementation where deficiency is confirmed, but the evidence for its role specifically in PPD prevention — while suggestive — requires further rigorous RCTs to establish causality.

4.2 Omega-3 Polyunsaturated Fatty Acids (DHA and EPA)

A growing body of clinical and epidemiological evidence suggests that low dietary intake and/or tissue levels of n-3 polyunsaturated fatty acids (PUFAs) are associated with postpartum depression. Low tissue levels of n-3 PUFAs, particularly docosahexaenoic acid (DHA), are reported in patients with either postpartum or non-puerperal depression. Moreover, the physiological demands of pregnancy and lactation put childbearing women at particular risk of experiencing a loss of DHA from tissues including the brain, especially in individuals with inadequate dietary n-3 PUFA intake or suboptimal metabolic capabilities.

Animal studies indicate that decreased brain DHA in postpartum females leads to several depression-associated neurobiological changes, including decreased hippocampal brain-derived neurotrophic factor and augmented hypothalamic-pituitary-adrenal responses to stress.

Scientific Evidence — Mixed and Contested: Despite a plausible biological mechanism, the clinical evidence for omega-3 supplementation in PPD prevention is inconclusive. In one study, women with low long-chain polyunsaturated fatty acid (LCP) intake supplemented with 220 mg of DHA showed no effect on depression, consistent with another study reporting no effect of 1.8 g of omega-3 PUFAs on maternal depressive symptoms. A trial involving 2,399 women found no significant difference in depressive symptoms between those receiving 800 mg of DHA and a control group during the first six months postpartum. A meta-analysis of 11 trials (N = 3,181) similarly found no significant difference in depression scores between the omega-3 and placebo groups, and no association between the daily doses of DHA or EPA and PPD prevention. The overall evidence is rated as insufficient to recommend omega-3 supplementation at any specific dosage for PPD prevention. Despite promising findings, the current literature presents inconsistencies and methodological limitations, underscoring the necessity for further rigorous research, including large-scale randomised controlled trials.

4.3 Vitamin D

Multiple studies suggest that low vitamin D levels may increase the risk of depression during and after pregnancy, though findings are inconsistent and affected by study design differences. The biological plausibility involves vitamin D's role in brain development, neurotransmitter function, and immune regulation. While some studies show a clear association, others have inconsistent results, possibly due to differing methodologies and the timing of vitamin D assessment. Some studies show biological evidence that supports vitamin D's neuroprotective and anti-inflammatory functions, which could influence mood regulation during and after pregnancy.

Scientific Evidence — Bone Health: Prenatal high-dose vitamin D supplementation reduced bone resorption during pregnancy (by one biomarker), albeit without evidence of a sustained effect in the postpartum period. Further evidence is therefore needed to substantiate potential maternal bone health benefits of vitamin D in the postpartum period. Vitamin D supplementation may reduce bone resorption or promote bone formation due to its role in the maintenance of calcium and bone-mineral homeostasis. The evidence strength for vitamin D in postpartum bone health and mood is currently observational and preliminary; well-powered intervention trials specifically in postpartum populations remain limited.

4.4 Folate (Vitamin B9) and Vitamin B12

Folate deficiency has been associated with depressive symptoms, and B12 deficiency is associated with inflammation — a mechanism implicated in the development of different psychiatric disorders. B vitamins do not have a direct impact on the HPA axis and immune system, but they manage the levels of homocysteine, a pro-inflammatory amino acid. When homocysteine is found in the body in excessive concentration, it leads to neurodegenerative diseases.

In a systematic review, individuals with diminished levels of vitamin B12 and zinc had an elevated risk of PPD. There was insufficient evidence for folate, magnesium, iron, and selenium, frequently due to methodological discrepancies, insufficient control of confounding variables, and variations in biomarker timing.

Scientific Evidence: Of studies reviewed in a systematic review on the subject, 31 reported a significant inverse association between perinatal depression and at least one of the following: vitamin D, iron status, vitamin B12, folate, or zinc. Research suggests that low levels of vitamin D, iron, folate, and carbohydrates, and an unhealthy diet lacking in vegetables are potential causes of PPD. Evidence is primarily observational; randomised trial data specifically targeting B12 or folate supplementation for PPD prevention in postpartum women are limited.

4.5 Zinc

Increasing evidence suggests that deficiencies in specific micronutrients, particularly vitamin D, vitamin B12, and zinc, may contribute to the onset of postpartum depression. The impact of zinc, omega-3 essential fatty acids, and other nutrients such as antioxidants, vitamin E, and vitamin C on PPD is unclear due to conflicting information. Zinc also plays a structural and functional role in wound healing, immune defence, and the maintenance of adequate breast milk composition. Evidence strength for zinc supplementation specifically in the postpartum period is currently weak and requires further investigation via well-designed RCTs.

4.6 Calcium

Mobilisation of maternal calcium stores is reflected by an increase in bone resorption and subsequent reduction in bone mineral density (BMD) and bone mineral content (BMC), with the hip and lumbar spine considered most susceptible. Bone losses during lactation were almost completely recovered at 12 months postpartum in adolescent mothers with dietary calcium intake at early lactation ranging from 890–1100 mg/d. The evidence for adolescent females suggests that increasing calcium intake during pregnancy or lactation may contribute to reducing the short-term postpartum bone losses. In adult women, the bone recovery after lactation cessation appears largely hormone-driven (PTHrP-mediated) rather than dietary-calcium-dependent, though adequate calcium intake remains a standard nutritional recommendation during this period.

5. Herbs and Natural Ingredients: Traditional Use vs. Scientific Evidence

5.1 Galactagogues — Overview

Herbal galactagogues are natural substances believed to stimulate, maintain, or augment breast milk production in lactating women. Traditionally used examples include fenugreek (Trigonella foenum-graecum), garlic (Allium sativum), shatavari (Asparagus racemosus), cumin (Cuminum cyminum), and moringa (Moringa oleifera). Their mechanisms of action are believed to involve stimulation of prolactin secretion, increased mammary gland development, and enhanced milk ejection. Some herbs, such as fenugreek and shatavari, contain phytoestrogens, which may contribute to their lactogenic effects by modulating hormonal pathways. Despite widespread traditional use, scientific evidence on the efficacy and safety of herbal galactagogues remains limited and inconsistent.

5.2 Fenugreek (Trigonella foenum-graecum)

Traditional Use: Fenugreek has been used since ancient times as a herbal galactagogue. It is a Greek hayseed originating in the Mediterranean, Southern Europe, and Western Asia, with documented use in Ayurvedic, Unani, and various North African and Middle Eastern traditional medicine systems to support lactation and postpartum recovery. Seeds are typically used in the form of teas, powders added to food, or encapsulated supplements.

Scientific Evidence: Eight blinded, placebo-controlled trials of herbal galactagogues have been identified, including 2 for fenugreek (Trigonella foenum-graecum), 2 for shatavari (Asparagus racemosus), 1 for a micronised form of silymarin, 1 for garlic, and 2 for moringa (Moringa oleifera). The overall body of evidence for fenugreek is small and methodologically heterogeneous. Studies on galactagogues varied in eligibility criteria, such as whether infants were term or preterm, which may have affected milk production by local feedback mechanisms or if the mothers have different breastfeeding practices — differences that may confound or modify the association observed. Evidence strength: weak to preliminary; larger, well-controlled RCTs are needed.

5.3 Shatavari (Asparagus racemosus)

Traditional Use: Asparagus racemosus (Shatavari) is a well-known herb that has been used as a galactagogue in traditional Indian culture and is also referenced in Ayurvedic medicine. In Ayurvedic texts, it is classified as a rasayana (rejuvenating tonic) and stanyajanana (milk-promoting herb), used postpartum to restore strength, support lactation, and balance reproductive physiology.

Scientific Evidence: Clinical studies have shown a positive effect of shatavari on the milk yield of lactating mothers. Oral administration of the herb increased the levels of prolactin approximately three times, due to steroidal saponins known as shatavarins I–IV. However, the effect of herbal galactagogues on prolactin levels was studied by Gupta and Shaw, who observed that shatavari increased serum prolactin level by 3.5 times that of placebo; however, that contradicted the results of Sharma et al., who found no galactagogue effect of shatavari. A double-blind, prospective, randomised, controlled clinical study using a shatavari and oats formulation (Shavari Bar®) was conducted at two centres in women with gestational age 37 weeks or more who intended to breastfeed; 78 women were randomised to receive either the shatavari-oat formulation or identical placebo. Evidence strength: preliminary to moderate, limited by small trial sizes and methodological inconsistency.

5.4 Moringa (Moringa oleifera)

Traditional Use: Moringa oleifera has been traditionally used as a galactagogue due to its rich micronutrient and phytosterol content. Due to its galactagogue ability, Moringa oleifera is known as "Mother's Best Friend" in traditional Filipino and African postpartum practice. Leaves are prepared as soups, teas, or dried leaf powders.

Scientific Evidence: A systematic review assessed the effects of moringa leaf supplementation on prolactin levels and breast milk volume in postpartum mothers with lactation insufficiency. A systematic search following PRISMA guidelines was conducted for RCTs involving healthy postpartum women. Risk of bias was evaluated using the Cochrane Risk of Bias Tool. Eight studies met the inclusion criteria, with intervention durations ranging from 3 to 10 days. Moringa supplementation significantly increased breast milk volume by up to 400 mL/day compared to controls. Moringa oleifera leaves also exhibit antimicrobial, anti-inflammatory, antioxidant, hepatoprotective, neuroprotective, hypoglycaemic, and blood lipid-lowering activities. Evidence strength: moderate for milk volume outcomes within the limitations of short-duration, small-sample RCTs; larger and longer trials are needed.

5.5 Milk Thistle Silymarin (Silybum marianum)

Traditional Use: Milk thistle (Silybum marianum) has been mentioned as a galactagogue alongside oats, dandelion, millet, seaweed, anise, basil, blessed thistle, fennel seeds, marshmallow, moringa leaf, shatavari, and torbangun among others. Its traditional use in European herbal medicine includes supporting liver function and — less prominently — milk production.

Scientific Evidence: A clinical study investigated a combination of Silybum marianum (400 mg) and Galega officinalis (150 mg) at a dose of once a day for six weeks, administered in pregnant mothers to determine its effect on breastfeeding and milk production, with newborn weight gain and prolactin levels recorded as outcomes. Evidence is limited to a small number of trials, some with methodological limitations; overall evidence strength is weak to preliminary.

5.6 Goat's Rue (Galega officinalis)

Traditional Use: Goat's rue has a long history of use in European and Middle Eastern herbal medicine as a galactagogue and general tonic. It was used in folk medicine to promote milk secretion by increasing mammary gland tissue development. The herb contains guanidine derivatives, which have been noted in the pharmacological literature.

Scientific Evidence: Despite widespread traditional use, scientific evidence on the efficacy and safety of herbal galactagogues, including goat's rue, remains limited and inconsistent. Some clinical studies suggest positive effects, such as increased milk volume and improved infant weight gain, while others show no significant benefit compared to placebo. Clinical evidence for goat's rue specifically is sparse; evidence strength is insufficient to draw firm conclusions.

5.7 Fennel (Foeniculum vulgare)

Traditional Use: Fennel seeds have been used in traditional Mediterranean, South Asian, and Chinese medicine postpartum for multiple purposes: to stimulate milk production, relieve postnatal digestive complaints (including gas and bloating), and as a general postpartum restorative, often prepared as a decoction or added to food.

Scientific Evidence: Herbal galactagogues, including fennel, are among the substances known as galactagogues (pharmaceutical and herbal compounds used to increase lactation), used to support sustainable milk production. However, specific high-quality RCT evidence for fennel in postpartum recovery is very limited. Evidence strength: insufficient based on current clinical literature.

5.8 Ashwagandha (Withania somnifera)

Traditional Use: In Ayurvedic medicine, ashwagandha is classified as a rasayana and has historically been recommended during postpartum recovery for its adaptogenic and restorative properties — including reducing fatigue, supporting thyroid function, and replenishing vitality after childbirth. It has not been traditionally used as a primary galactagogue.

Scientific Evidence: While ashwagandha has been studied in general populations for stress and fatigue, specific high-quality clinical evidence in postpartum populations is not yet established in the peer-reviewed literature reviewed for this article. The available evidence for its postpartum application is therefore insufficient for firm conclusions.

6. Dietary Patterns and Macronutrients in Postpartum Recovery

6.1 Overall Energy and Macronutrient Needs

The RDAs for most nutrients are increased during lactation — in some cases by more than 50%. The extra nutrient intake needed to cover exclusive breastfeeding for 4 to 6 months is substantially greater than that needed to cover the entire pregnancy. Changes in energy intake vary considerably between studies; however, there is a general trend toward a significant increase in energy intake in lactating women 3–4 months postpartum compared with the third trimester.

Adequate nutrition during pregnancy and postpartum is critical to maternal and child health, but there is often a missing focus around health outcomes specifically for women.

6.2 Dietary Quality and Mental Health

Postpartum depression is a common illness with long-term effects on mother and child. Nutrition is a crucial factor in mental health, but research findings on its connection to PPD are inconsistent. Adequate and balanced nutrition of the mother in the postpartum period is a basic requirement for the protection and development of mental health. Especially omega-3 fatty acids, vitamin B12, vitamin D, selenium, and iodine consumption are considered important for healthy mental health. In the latest reports of the World Health Organization, the importance of seafood between pregnancy and mental health has been emphasised.

6.3 Gut Microbiome and Postpartum Recovery

A burgeoning body of evidence points to intricate bidirectional communication between the brain and gut, with the microbial denizens and their metabolic by-products playing pivotal roles — a dialogue known as the brain-gut-microbiota axis. In patients with PPD, a relatively lower abundance of the Firmicutes phylum has been observed.

A systematic review and meta-analysis aimed to synthesise evidence from RCTs on the efficacy of gut microbiome-targeted interventions in improving mental health symptoms in women undergoing key hormonal transitions. Results from meta-analyses indicated that women who received interventions such as probiotics, prebiotics, or paraprobiotics experienced a significant reduction in symptoms of depression (SMD = −0.848, p = 0.008) and anxiety (SMD = −0.997, p = 0.004) compared to control groups. Evidence in this domain is emerging and promising but the field is young; optimal strains, doses, and durations for postpartum use remain to be established.

7. Lifestyle Factors in Postpartum Recovery

7.1 Physical Activity

The benefits of postpartum exercise include reducing fatigue and promoting better sleep, strengthening and toning abdominal muscles, weight loss and return to pre-pregnancy weight, prevention of lactation-associated bone loss, and improving fitness level.

Statistically significant differences were found in general health components, vitality, emotional role, and mental health in women who practised hypopressive exercise postpartum; these scores were higher at the end of the programme and in the exercise group. A hypopressive physical exercise training programme improves quality of life after childbirth.

7.2 Sleep

Modifiable cognitive factors (such as sleep-related worry) and behavioural factors (such as social media use) impact sleep after childbirth. Fatigue from poor sleep hinders postpartum exercise, yet exercise improves both mood and sleep quality. The relationship between sleep disruption and postpartum mood disturbance is bidirectional and well-documented in the literature; sleep protection has been proposed as a key modifiable component of PPD prevention.

7.3 Breastfeeding Status

In a prospective cohort study, mothers who were breastfeeding had significantly lower PPD scores compared to those who were not breastfeeding (mean score 3.9 ± 3.5 vs. 7.6 ± 4.8, p = 0.048). The relationship is complex and bidirectional; it is not yet established whether breastfeeding itself is protective, or whether the same factors that support breastfeeding success also confer mental health resilience.

7.4 Socioeconomic and Structural Factors

At six months postpartum, PPD was positively correlated to BMI and fatigue, and negatively correlated to household income. Elevated prevalence rates of PPD are observed in low- and middle-income countries where systemic barriers to care and nutritional insecurity are prevalent. Rates in certain high-risk populations — such as adolescent mothers, individuals with a history of mood disorders, and those experiencing intimate partner abuse — may exceed 30%.

8. Evidence Summary and Strength of Evidence

• Iron: Strong observational evidence for postpartum depletion and anaemia; clinical trial evidence supports supplementation in iron-deficient women for both haematological and mood outcomes. Evidence strength: moderate to strong for iron repletion where deficiency is confirmed.
• Omega-3 fatty acids (DHA/EPA): Biologically plausible association with PPD risk; however, meta-analysis of RCTs does not support supplementation for PPD prevention at current dosages tested. Evidence strength: weak to insufficient for supplementation; observational associations remain.
• Vitamin D: Multiple observational studies link low vitamin D to increased PPD risk; intervention trial evidence for postpartum outcomes is limited and inconsistent. Bone resorption during lactation is not reliably modified by vitamin D supplementation postpartum in existing trial data. Evidence strength: preliminary to moderate (observational); weak (interventional).
• Folate and B12: Observational associations with perinatal depression are established; direct interventional RCT data for PPD prevention are sparse. Evidence strength: preliminary.
• Zinc: Associated with elevated PPD risk when deficient; interventional evidence is lacking. Evidence strength: preliminary.
• Moringa (M. oleifera): Most evidence-supported herbal galactagogue for milk volume, based on systematic review of short-duration RCTs. Evidence strength: moderate (within limitations of trial duration and size).
• Shatavari (A. racemosus): Conflicting clinical trial results for prolactin and milk output. Evidence strength: preliminary and inconsistent.
• Fenugreek (T. foenum-graecum): Limited blinded RCT data; widely used but evidence strength: weak to preliminary.
• Probiotics/gut microbiome interventions: Emerging meta-analytic evidence for reductions in depression and anxiety; specific postpartum applications still under investigation. Evidence strength: preliminary to moderate.
• Physical activity: Consistent evidence across multiple study types for improved mood, sleep, bone health, and quality of life postpartum. Evidence strength: moderate to strong.

References

• Chauhan G, Tadi P. Physiology, Postpartum Changes. StatPearls [Internet]. NCBI Bookshelf.
• Wu X, Jin R. Effects of postpartum hormonal changes on the immune system and their role in recovery. Frontiers in Allergy and Bioscience. 2025.
• Rebelo F et al. Postpartum changes in body composition. PubMed. 2011.
• Tracking of Maternal Diet from Pregnancy to Postpregnancy: A Systematic Review. ScienceDirect / Journal of the Academy of Nutrition and Dietetics. 2022.
• Current evidence around key underrepresented women's health topics in pregnancy and postpartum nutrition: a narrative review. Applied Physiology, Nutrition, and Metabolism. 2024.
• Invisible Links: Associations Between Micronutrient Deficiencies and Postpartum Depression — A Systematic Review. PMC. 2025.
• Nutritional Concerns of Women in the Preconceptional, Prenatal, and Postpartum Periods. Nutrition Services in Perinatal Care. NCBI Bookshelf.
• Current concepts in postpartum anemia management. PMC / Current Opinion in Anaesthesiology. 2024.
• Prevalence of postpartum anaemia and iron deficiency by serum ferritin, soluble transferrin receptor and total body iron: a Norwegian population-based cohort study. PMC / Journal of Nutritional Science. 2022.
• Llorente AM et al. N-3 (Omega-3) Fatty Acids in Postpartum Depression: Implications for Prevention and Treatment. PMC / CNS Neuroscience & Therapeutics. 2010.
• Omega-3 and Postpartum Depression: Assessing the Effectiveness of Omega-3 PUFAs in Preventing Postpartum Depression. PMC. 2025.
• Prenatal but not continued postpartum vitamin D supplementation reduces maternal bone resorption. PMC / Frontiers in Nutrition. 2024.
• African-American Bone Metabolism and Lactation Study. ClinicalTrials.gov.
• Apostolidou I et al. Relationship Between Vitamin D Deficiency and Postpartum Depression. PMC / Journal of Personalised Medicine. 2025.
• A Systematic Review of the Correlation Between Micronutrient Levels and Perinatal Depression. Nutrients. 2025.
• The Association between Post-Partum Depression and Nutrition and Dietary Patterns: Systematic Review. PMC / Iranian Journal of Nursing and Midwifery Research. 2024.
• Postpartum depression: aetiology, pathogenesis and the role of nutrients and dietary supplements in prevention and management. PMC / Biomedicine & Pharmacotherapy. 2023.
• A Review of Herbal and Pharmaceutical Galactagogues for Breast-Feeding. PMC / Ochsner Journal. 2016.
• Moringa oleifera Supplementation as a Natural Galactagogue: A Systematic Review on Its Role in Supporting Milk Volume and Prolactin Levels. PMC / Foods. 2025.
• ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting the Rate of Maternal Milk Secretion. Academy of Breastfeeding Medicine. 2018.
• Postpartum Use of Shavari Bar® Improves Breast Milk Output: A Double-Blind, Prospective, Randomized, Controlled Clinical Study. PMC. 2022.
• Ethnopharmacology of Botanical Galactagogues and Comprehensive Analysis of Gaps Between Traditional and Scientific Evidence. Current Research in Nutrition and Food Science Journal. 2023.
• Evaluation of early postpartum fenugreek supplementation on expressed breast milk volume and prolactin levels variation. ScienceDirect / Egyptian Pediatric Association Gazette. 2018.
• Modifiable Maternal Factors and Their Relationship to Postpartum Depression. PMC. 2022.
• Association of Physical Activity with the Prevention and Treatment of Depression During the Postpartum Period: A Narrative Review. PMC. 2023.
• Quality of Life in the Postpartum Recovery of Women Who Practice Hypopressive Exercise: Randomized Clinical Trial. PMC. 2022.
• Postpartum dietary, sleep, and physical activity behaviors: A qualitative study to inform efforts to address postpartum weight retention. PMC. 2025.
• Jin W et al. The causal association between gut microbiota and postpartum depression: a two-sample Mendelian randomization study. Frontiers in Microbiology. 2024.
• Efficacy of Gut Microbiome-Targeted Interventions on Mental Health Symptoms in Women Across Key Hormonal Life Stages: A Systematic Review and Meta-Analysis. Healthcare. 2025.
• The effect of omega-3 fatty acid use on women's mental health in postpartum depression: a systematic review and meta-analysis. PMC. 2024.